Related Experiment Video
Updated: Jan 13, 2026

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients
Tyler Shugg1, Katherine A Gallaway1, Nick Powell1
1Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Introduction:
Wide-spread use of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulators has resulted in a dramatic increase in life expectancy of people with CF. Historically, CFTR carrier status has been thought to be benign; however, data are emerging that dysfunction of CFTR may play a role in cancer risk. The aims of this study were to (1) determine the frequency of germline pathogenic CFTR gene variations in a cohort of patients with cancer, and (2) investigate associations between germline pathogenic CFTR variants and established germline somatic oncogenic driver mutations.
Methods:
The Indiana University Adult Precision Genomics (APG) clinical database was queried for all subjects having a germline CFTR pathogenic variant (PV). The CFTR PVs observed in our cohort were compared to published population minor allele frequencies from the Allele Frequency Aggregator (ALFA) Project then scaled to reflect our APG population.
Results:
Data were available for 2141 patients. Based on known minor allele frequencies and the racial distribution of our cohort, we expected 33 subjects (1.5%) to have CFTR PVs. However, CFTR PVs were present in 71 subjects (3.3%), 2.1-fold higher than expected (p < 0.001). The observed enrichment of CFTR PVs varied by cancer type, with CFTR PVs being overrepresented in patients with skin and gastrointestinal cancers.
Conclusions:
The overall prevalence of CFTR PVs in people with solid tumors was higher than expected. These results suggest that carriers of CFTR PV may benefit from enhanced cancer screening.
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...